BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20799158)

  • 1. [Ocular manifestations in xeroderma pigmentosum].
    Süsskind D; Berneburg M; Rohrbach JM
    Klin Monbl Augenheilkd; 2011 Mar; 228(3):239-44. PubMed ID: 20799158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Xeroderma pigmentosum and related syndromes].
    Berneburg M; Krutmann J
    Hautarzt; 2003 Jan; 54(1):33-40. PubMed ID: 12567255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.
    Brooks BP; Thompson AH; Bishop RJ; Clayton JA; Chan CC; Tsilou ET; Zein WM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Iliff NT; Bradford P; Digiovanna JJ; Kraemer KH
    Ophthalmology; 2013 Jul; 120(7):1324-36. PubMed ID: 23601806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma Pigmentosum - Cockayne Syndrome Complex (XP-CS) - Another case.
    Metlo A; Rehan A; Akmal M; Iqbal U; Jamali M
    J Pak Med Assoc; 2018 Oct; 68(10):1531-1534. PubMed ID: 30317357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in chromosome breakage syndromes and their diagnosis.
    Mathur R; Chowdhury MR; Singh G
    Indian Pediatr; 2000 Jun; 37(6):615-25. PubMed ID: 10869141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum-Cockayne syndrome complex.
    Natale V; Raquer H
    Orphanet J Rare Dis; 2017 Apr; 12(1):65. PubMed ID: 28376890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary disease with hyper-sensitivity to radiation].
    Suzuki N; Kojima T; Sugita K
    Nihon Rinsho; 1993 Jan; 51 Suppl():1078-86. PubMed ID: 8459531
    [No Abstract]   [Full Text] [Related]  

  • 8. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ophtalmologic manifestations of the xeroderma pigmentosum].
    Mseddi M; Sellami D; Elloumi Y; Aloulou Y; Kammoun B; Turki H; Feki J; Zahaf A
    Tunis Med; 2006 Sep; 84(9):542-4. PubMed ID: 17263199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features.
    Fujimoto M; Leech SN; Theron T; Mori M; Fawcett H; Botta E; Nozaki Y; Yamagata T; Moriwaki S; Stefanini M; Momoi MY; Nakagawa H; Shuster S; Moss C; Lehmann AR
    J Invest Dermatol; 2005 Jul; 125(1):86-92. PubMed ID: 15982307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeroderma pigmentosum: beyond skin cancer.
    Lichon V; Khachemoune A
    J Drugs Dermatol; 2007 Mar; 6(3):281-8. PubMed ID: 17373189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
    Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
    Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular manifestations in a patient with Cockayne syndrome and simultaneous reduced DNA repair].
    Lang GE; Gebhart E; Lang C; Naumann GO
    Klin Monbl Augenheilkd; 1991 Jun; 199(1):36-9. PubMed ID: 1895738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-radioisotope method for diagnosing photosensitive genodermatoses and a new marker for xeroderma pigmentosum variant.
    Hashimoto S; Egawa K; Ihn H; Tateishi S
    J Dermatol; 2009 Mar; 36(3):138-43. PubMed ID: 19335687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.
    Kleijer WJ; Laugel V; Berneburg M; Nardo T; Fawcett H; Gratchev A; Jaspers NG; Sarasin A; Stefanini M; Lehmann AR
    DNA Repair (Amst); 2008 May; 7(5):744-50. PubMed ID: 18329345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain vascular changes in Cockayne syndrome.
    Hayashi M; Miwa-Saito N; Tanuma N; Kubota M
    Neuropathology; 2012 Apr; 32(2):113-7. PubMed ID: 21749465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum: a case report and review of the literature.
    Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
    J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Xeroderma pigmentosum. A study in 40 Algerian patients].
    Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
    Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.
    Cleaver JE; Thompson LH; Richardson AS; States JC
    Hum Mutat; 1999; 14(1):9-22. PubMed ID: 10447254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.